Last updated: June 3, 2025
Sponsor: M.D. Anderson Cancer Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Thyroid Cancer
Treatment
N/AClinical Study ID
NCT06507878
2024-0394
NCI-2024-06148
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
All adult patients aged 18 years or older with anaplastic thyroid cancer or poorly differentiated thyroid cancer as their clinical and/ or histological diagnosis will be included.
Exclusion
Exclusion Criteria:
Patients who do not have anaplastic thyroid cancer or poorly differentiated thyroid cancer on their tumor tissue would be excluded.
Study Design
Total Participants: 459
Study Start date:
December 05, 2024
Estimated Completion Date:
July 01, 2034
Study Description
Connect with a study center
MD Anderson Cancer Center
Houston, Texas 77030
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.